logo

NUVB

Nuvation Bio·NYSE
--
--(--)
--
--(--)
6.03 / 10
Outperform

Analyst coverage is uniformly bullish with two active analysts, both rating NUVB as Buy. Institutional sentiment is supportive, and medium/large fund flows exhibit positive trends, although overall flow is negative. This divergence suggests that while retail sentiment may be cooling, professional investors continue to lean in, providing a potential floor for the share price.

FundamentalSentiment(6.03)Technical
Fund Flow Rating
Analyst RatingBuy

Wall Street Opinions

Buy

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

Date2026-02-10
InstitutionWedbush
Times predicted5
Historical Win Rate60.0%
Is money flowing into or out of NUVB?
  • NUVB holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.03/10 (Outperform).